CalciMedica (CALC) vs Vistagen Therapeutics (VTGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CalciMedica (CALC) has outperformed Vistagen Therapeutics (VTGN) over the past year, losing 91.3% versus a loss of 93.8%. Vistagen Therapeutics is the larger company by market cap ($11.0 million vs $9.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CALC | VTGN |
|---|---|---|
| Share price | $1.34 | $0.2476 |
| Market cap | $9.15M | $10.99M |
| 1-day change | -9.46% | +0.20% |
| YTD return | -95.51% | -62.56% |
| 1-year return | -91.27% | -93.76% |
| 5-year return | — | -99.66% |
| EPS (TTM) | $-6.85 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $36.00 | $5.14 |
| 52-week low | $1.33 | $0.20 |
| Distance from 52-week high | -96.28% | -95.18% |
| Average volume | 73.03K | 12.38M |
| Shares outstanding | 6.83M | 44.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CALC vs VTGN FAQ
Which is bigger, CalciMedica or Vistagen Therapeutics?
Vistagen Therapeutics (VTGN) is larger, with a market capitalization of $10.99M compared with $9.15M for CalciMedica (CALC).
Which stock has performed better over the past year, CALC or VTGN?
CALC returned -91.27% over the past 12 months, compared with -93.76% for VTGN (price return, excluding dividends). Past performance does not predict future results.
Are CalciMedica and Vistagen Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.